Bartira Rossi-Bergmann

About Bartira Rossi-Bergmann

Bartira Rossi-Bergmann, With an exceptional h-index of 41 and a recent h-index of 23 (since 2020), a distinguished researcher at Universidade Federal do Rio de Janeiro, specializes in the field of Leishmaniasis, drug target, drug delivery, nanobiotechnology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Synthesis and evaluation of hybrid sulfonamide‐chalcones with potential antileishmanial activity

Intranasal delivery of LaAg vaccine improves immunity of aged mice against visceral Leishmaniasis

Crosslinked chitosan microparticles as a safe and efficient DNA carrier for intranasal vaccination against cutaneous leishmaniasis

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control

Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in …

Immunogenicity of SARS-CoV-2 trimeric spike protein associated to poly (I: C) plus alum

Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe

In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis

Bartira Rossi-Bergmann Information

University

Position

- Brazil

Citations(all)

4948

Citations(since 2020)

1685

Cited By

4001

hIndex(all)

41

hIndex(since 2020)

23

i10Index(all)

84

i10Index(since 2020)

62

Email

University Profile Page

Google Scholar

Bartira Rossi-Bergmann Skills & Research Interests

Leishmaniasis

drug target

drug delivery

nanobiotechnology

Top articles of Bartira Rossi-Bergmann

Title

Journal

Author(s)

Publication Date

Synthesis and evaluation of hybrid sulfonamide‐chalcones with potential antileishmanial activity

Archiv der Pharmazie

Nathalia S de Oliveira

Luana G de Souza

Vitor M de Almeida

Arielly RR Barreto

Felipe Carvalho‐Gondim

...

2024/3

Intranasal delivery of LaAg vaccine improves immunity of aged mice against visceral Leishmaniasis

Acta Tropica

Caio Loureiro Salgado

Andrés Felipe Mendéz Corea

Luciana Polaco Covre

Alessandra Marcia da Fonseca-Martins

Aloisio Falqueto

...

2024/4/1

Crosslinked chitosan microparticles as a safe and efficient DNA carrier for intranasal vaccination against cutaneous leishmaniasis

Vaccine: X

Beatriz LS Costa Souza

Eduardo F Pinto

Izabella PS Bezerra

Daniel CO Gomes

Ana Maria B Martinez

...

2023/12/1

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control

Frontiers in Cellular and Infection Microbiology

Letícia Paula Trajano Noronha

Monique Daiane Andrade Martins

Archimedes Barbosa Castro-Junior

Maria Luiza Thorstenberg

Laís Costa-Soares

...

2023/6/12

Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in …

Frontiers in Cellular and Infection Microbiology

Sarfaraz Ahmad Ejazi

Samiran Saha

Anirban Bhattacharyya

Sonali Das

Nathália Lopes Fontoura Mateus

...

2022/7/1

Immunogenicity of SARS-CoV-2 trimeric spike protein associated to poly (I: C) plus alum

Frontiers in immunology

Júlio Souza Dos-Santos

Luan Firmino-Cruz

Alessandra Marcia da Fonseca-Martins

Diogo Oliveira-Maciel

Gustavo Guadagnini Perez

...

2022/6/30

Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe

Biomedicine & Pharmacotherapy

Ariane S Batista

Suellen DS Oliveira

Sébastien Pomel

Pierre-Henri Commere

Valérie Mazan

...

2022/5/1

In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis

Pharmaceutics

Ariane de J Sousa-Batista

Natalia Arruda-Costa

Wallace Pacienza-Lima

Felipe Carvalho-Gondim

Rosiane F Santos

...

2022/12/24

Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis

Microbes and Infection

Daniel Claudio Oliveira Gomes

Beatriz Lilian da Silva Costa Souza

Rodrigo Porto Schwedersky

Luciana Polaco Covre

Herbert Leonel de Matos Guedes

...

2022/3/1

Intradermal immunization of SARS-CoV-2 original strain trimeric spike protein associated to cpG and addaS03 adjuvants, but not MPL, provide strong humoral and cellular response …

Vaccines

Luan Firmino-Cruz

Júlio Souza Dos-Santos

Alessandra Marcia da Fonseca-Martins

Diogo Oliveira-Maciel

Gustavo Guadagnini-Perez

...

2022/8/12

Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs

Douglas O Escrivani

Gabriela C Mattos

Bartira Rossi-Bergmann

Ariane J Sousa-Batista

2021/11/30

Chalcones identify cTXNPx as a potential antileishmanial drug target

PLoS neglected tropical diseases

Douglas O Escrivani

Rebecca L Charlton

Marjolly B Caruso

Gabriela A Burle-Caldas

Maria Paula G Borsodi

...

2021/11/15

MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis

Microorganisms

Diogo Oliveira-Maciel

Júlio Souza Dos-Santos

Gabriel Oliveira-Silva

Mirian França de Mello

Alessandra Marcia da Fonseca-Martins

...

2021/6/11

Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles

Parasitology

Ariane J Sousa-Batista

Natalia Arruda-Costa

Douglas O Escrivani

Franceline Reynaud

Patrick G Steel

...

2020/8

Leishmanicidal activity of Piper marginatum Jacq. from Santarém-PA against Leishmania amazonensis

Experimental parasitology

Caroline Gomes Macêdo

Maria Yasmin Nogueira Fonseca

Antônia Djane Caldeira

Santana Pinto Castro

Wallace Pacienza-Lima

...

2020/3/1

Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8

Nanomedicine: Nanotechnology, Biology and Medicine

Douglas O Escrivani

Milene Valéria Lopes

Fernanda Poletto

Stela Regina Ferrarini

Ariane J Sousa-Batista

...

2020/2/1

Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase

ACS infectious diseases

John GM Mina

Rebecca L Charlton

Edubiel Alpizar-Sosa

Douglas O Escrivani

Christopher Brown

...

2020/12/8

Vitamin D increases killing of intracellular Leishmania amazonensis in vitro independently of macrophage oxidative mechanisms

Parasitology

Patrícia de Almeida Machado

Douglas Oliveira Escrivani

Daniel Claudio Oliveira Gomes

Bartira Rossi-Bergmann

Suzana Passos Chaves

...

2020/12

Nanoparticles loaded with a new thiourea derivative: development and in vitro evaluation against Leishmania amazonensis

Current Drug Delivery

Paloma W Meireles

Dandara PB de Souza

Marianne Grilo Rezende

Maria Paula Gonçalves Borsodi

Douglas Escrivani De Oliveira

...

2020/10/1

See List of Professors in Bartira Rossi-Bergmann University(Universidade Federal do Rio de Janeiro)

Co-Authors

academic-engine